Functional biomarkers for neurodegenerative disorders based on the network paradigm

Progress in Neurobiology

Volumn 95, Issue 4, 2011, Pages 505-509

  Horwitz, Barry ^a   Rowe, James B ^b,c  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MRC COGNITION AND BRAIN SCIENCES UNIT   (United Kingdom)

Author keywords

Dementia; Effective connectivity; FMRI; Functional connectivity; Parkinson's disease; PET

Indexed keywords

BIOLOGICAL MARKER;

BRAIN REGION; DEGENERATIVE DISEASE; DEMENTIA; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; NEUROIMAGING; NOTE; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; BRAIN; BRAIN MAPPING; HUMANS; MAGNETIC RESONANCE IMAGING; NEURAL PATHWAYS; NEURODEGENERATIVE DISEASES; POSITRON-EMISSION TOMOGRAPHY;

EID: 82755193656     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2011.07.005     Document Type: Note

References (34)

1. Asanuma K., Tang C., Ma Y., Dhawan V., Mattis P., Edwards C., Kaplitt M.G., Feigin A., Eidelberg D. Network modulation in the treatment of Parkinson's disease. Brain 2006, 129:2667-2678.
2. Beckmann C.F., DeLuca M., Devlin J.T., Smith S.M. Investigations into resting-state connectivity using independent component analysis. Phil. Trans. R. Soc. Lond. B 2005, 360:1001-1013.
3. Bokde A.L.W., Ewers M., Hampel H. Assessing neuronal networks: understanding Alzheimer's disease. Prog. Neurobiol. 2009, 89:125-133.
4. Buckner R.L., Snyder A.Z., Shannon B.J., LaRossa G., Sachs R., Fotenos A.F., Sheline Y.I., Klunk W.E., Mathis C.A., Morris J.C., Mintun M.A. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J. Neurosci. 2005, 25:7709-7717.
5. Bullmore E., Sporns O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat. Rev. Neurosci. 2009, 10:186-198.
6. Damoiseaux J.S., Smith S.M., Witter M.P., Sanz-Arigita E.J., Barkhof F., Scheltens P., Stam C.J., Zarei M., Rombouts S.A. White matter tract integrity in aging and Alzheimer's disease. Hum. Brain Mapp. 2009, 30:1051-1059.
7. Filippini N., MacIntosh B.J., Hough M.G., Goodwin G.M., Frisoni G.B., Smith S.M., Matthews P.M., Beckmann C.F., Mackay C.E. Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:7209-7214.
8. Friston K., Kiebel S. Predictive coding under the free-energy principle. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2009, 364:1211-1221.
9. Friston K.J., Buechel C., Fink G.R., Morris J., Rolls E., Dolan R.J. Psychophysiological and modulatory interactions in neuroimaging. Neuroimage 1997, 6:218-229.
10. Friston K.J., Harrison L., Penny W. Dynamic causal modelling. Neuroimage 2003, 19:1273-1302.
11. Grafton S.T., Sutton J., Couldwell W., Lew M., Waterm C. Network analysis of motor system connectivity in Parkinsons's disease: modulation of thalamocortical interactions after pallidotomy. Hum. Brain Mapp. 1994, 2:45-55.
12. Greicius M.D., Krasnow B., Reiss A.L., Menon V. Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:253-258.
13. Hampel H., Frank R., Broich K., Teipel S.J., Katz R.G., Hardy J., Herholz K., Bokde A.L., Jessen F., Hoessler Y.C., Sanhai W.R., Zetterberg H., Woodcock J., Blennow K. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives. Nat. Rev. Drug Discov. 2010, 9:560-574.
14. Hampel H., Wilcock G., Andrieu S., Aisen P., Blennow K., Broich K., Carrillo M., Fox N.C., Frisoni G.B., Isaac M., Lovestone S., Nordberg A., Prvulovic D., Sampaio C., Scheltens P., Weiner M., Winblad B., Coley N., Vellas B. Biomarkers for Alzheimer's disease therapeutic trials. Prog. Neurobiol. 2011, 95:579-593.
15. Horwitz B., Grady C.L., Schlageter N.L., Duara R., Rapoport S.I. Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease. Brain Res. 1987, 407:294-306.
16. Horwitz B., McIntosh A.R., Haxby J.V., Furey M., Salerno J.A., Schapiro M.B., Rapoport S.I., Grady C.L. Network analysis of PET-mapped visual pathways in Alzheimer type dementia. Neuroreport 1995, 6:2287-2292.
17. Horwitz B., Tagamets M.-A., McIntosh A.R. Neural modeling, functional brain imaging, and cognition. Trends Cogn. Sci. 1999, 3:91-98.
18. Horwitz B., Warner B., Fitzer J., Tagamets M.-A., Husain F.T., Long T.W. Investigating the neural basis for functional and effective connectivity: application to fMRI. Philos. Trans. R. Soc. Lond. B 2005, 360:1093-1108.
19. Kim J., Horwitz B. How well does structural equation modeling reveal abnormal brain anatomical connections? An fMRI simulation study. Neuroimage 2009, 45:1190-1198.
20. Lustig C., Snyder A.Z., Bhakta M., O'Brien K.C., McAvoy M., Raichle M.E., Morris J.C., Buckner R.L. Functional deactivations: change with age and dementia of the Alzheimer type. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:14504-14509.
21. Marreiros A.C., Kiebel S.J., Friston K.J. Dynamic causal modelling for fMRI: a two-state model. Neuroimage 2008, 39:269-278.
22. McIntosh A.R., Gonzalez-Lima F. Structural equation modeling and its application to network analysis in functional brain imaging. Hum. Brain Mapp. 1994, 2:2-22.
23. McIntosh A.R., Grady C.L., Ungerleider L.G., Haxby J.V., Rapoport S.I., Horwitz B. Network analysis of cortical visual pathways mapped with PET. J. Neurosci. 1994, 14:655-666.
24. Metter E.J., Riege W.H., Kameyama M., Kuhl D.E., Phelps M.E. Cerebral metabolic relationships for selected brain regions in Alzheimer's Huntington's and Parkinson's diseases. J. Cereb. Blood Flow Metab. 1984, 4:500-506.
25. Prvulovic D., Bokde A.L.W., Faltraco F., Hampel H. Functional magnetic resonance imaging as a dynamic candidate biomarker for Alzheimer's disease. Prog. Neurobiol. 2011, 557-569.
26. Raichle M.E., MacLeod A.M., Snyder A.Z., Powers W.J., Gusnard D.A., Shulman G.L. A default mode of brain function. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:676-682.
27. Rombouts S.A., Barkhof F., Goekoop R., Stam C.J., Scheltens P. Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study. Hum. Brain Mapp. 2005, 26:231-239.
28. Rowe J.B. Connectivity analysis is essential to understand neurological disorders. Front Syst. Neurosci. 2010, 4:144.
29. Rowe J.B., Hughes L.E., Barker R.A., Owen A.M. Dynamic causal modelling of effective connectivity from fMRI: are results reproducible and sensitive to Parkinson's disease and its treatment?. Neuroimage 2010, 52:1015-1026.
30. Smith J.F., Pillai A., Chen K., Horwitz B. Identification and validation of effective connectivity networks in functional magnetic resonance imaging using switching linear dynamic systems. Neuroimage 2010, 52:1027-1040.
31. Sonty S.P., Mesulam M.M., Weintraub S., Johnson N.A., Parrish T.B., Gitelman D.R. Altered effective connectivity within the language network in primary progressive aphasia. J. Neurosci. 2007, 27:1334-1345.
32. Teipel S.J., Meindl T., Wagner M., Stieltjes B., Reuter S., Hauenstein K.H., Filippi M., Ernemann U., Reiser M.F., Hampel H. Longitudinal changes in fiber tract integrity in healthy aging and mild cognitive impairment: a DTI follow-up study. J. Alzheimers Dis. 2010, 22:507-522.
33. Wendling F., Ansari-Asl K., Bartolomei F., Senhadji L. From EEG signals to brain connectivity: a model-based evaluation of interdependence measures. J. Neurosci. Methods 2009, 183:9-18.
34. Zhou J., Greicius M.D., Gennatas E.D., Growdon M.E., Jang J.Y., Rabinovici G.D., Kramer J.H., Weiner M., Miller B.L., Seeley W.W. Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. Brain 2010, 133:1352-1367.